News + PR Wheeler Bio Licenses ATUM's Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering Read More
News + PR Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma Read More
News + PR Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency across their Cell Line Development Workflow Read More
News + PR Alloy Therapeutics and Echo Investment Capital Create Wheeler Bio to Accelerate the Development of New Antibody Therapeutics Read More
